|
DVL2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.757000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.939430E-01 |
| Normal-vs-Stage2 |
4.288000E-01 |
| Normal-vs-Stage3 |
2.184600E-01 |
| Normal-vs-Stage4 |
7.344400E-01 |
| Stage1-vs-Stage2 |
8.547400E-01 |
| Stage1-vs-Stage3 |
9.492600E-01 |
| Stage1-vs-Stage4 |
1.039640E-01 |
| Stage2-vs-Stage3 |
9.068600E-01 |
| Stage2-vs-Stage4 |
3.184000E-01 |
| Stage3-vs-Stage4 |
1.361040E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.401400E-01 |
| Normal-vs-AfricanAmerican |
6.985800E-01 |
| Normal-vs-Asian |
6.399600E-01 |
| Caucasian-vs-AfricanAmerican |
3.540400E-01 |
| Caucasian-vs-Asian |
8.404400E-01 |
| AfricanAmerican-vs-Asian |
4.700800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.809200E-01 |
| Normal-vs-Female |
2.973400E-01 |
| Male-vs-Female |
8.734800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.189600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.343000E-01 |
| Normal-vs-Age(61-80Yrs) |
4.705800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.469980E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.228200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.966400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.042800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.121600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.179000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.228010E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.398560E-01 |
| Classical-VS-Follicular |
1.76564999999629E-05 |
| Classical-VS-Other |
3.909800E-01 |
| Classical-VS-Normal |
8.255000E-01 |
| Tall-VS-Follicular |
4.578300E-02 |
| Tall-VS-Other |
9.356400E-01 |
| Tall-VS-Normal |
2.349200E-01 |
| Follicular-VS-Other |
4.617800E-01 |
| Follicular-VS-Normal |
9.950400E-04 |
| Other-VS-Normal |
4.623800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.541600E-02 |
| Normal-vs-N1 |
2.568200E-01 |
| N0-vs-N1 |
8.993600E-01 |
|
|
